SOLICITATION NOTICE
R -- FDA On-Site Records and Information Management (RIM) - Package #1
- Notice Date
- 8/13/2013
- Notice Type
- Presolicitation
- NAICS
- 541611
— Administrative Management and General Management Consulting Services
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-On-Site-RIM-00014
- Archive Date
- 9/7/2013
- Point of Contact
- Elvis R. Colbert, Phone: 3018276791
- E-Mail Address
-
elvis.colbert@fda.hhs.gov
(elvis.colbert@fda.hhs.gov)
- Small Business Set-Aside
- Competitive 8(a)
- Description
- Summary of Volume Submissions List of Document Control Facilities Draft SOW Synopsis: PRESOLICITATION NOTICE ADVISORY MULTI-STEP PROCESS. Please read this entire notice carefully as it constitutes the only notice that will be issued regarding the Food and Drug Administration (FDA) Agency-Wide Records Information Management (RIM) Advisory Multi-Step Process. The FDA intends to award a competitive single- award Hybrid Firm Fixed Price/Labor Hour/Time and Materials IDIQ type contract to an 8(a) contractor/contractor team with the proven ability to provide support services to include: Records Lifecycle Activities, Quality Control, Records Information Management, Storage Services, Onsite Document Control Scanning, and Training for a very high volume of FDA records across several locations in the Washington D.C. metropolitan area. The successful contractor must demonstrate the ability to plan and execute RIM activities relative to various FDA Center's missions, resources, and personnel. The Government anticipates that the majority of this effort may be performed under NAICS code 541611 (Administrative Management and General Management Consulting). All documents applicable to this pre-solicitation notice have been submitted as attachments. The FDA welcomes any comments and/or suggestions via track changes on the draft SOW. Interested parties are invited to respond to this Presolicitation Notice, which is issued following the procedures described under FAR 15.202 entitled "Advisory multi-step process". The result of this pre-solicitation notice will help determine if sources capable of satisfying the agency's requirements exist. Additionally, it is not the Government's intention to enter into a contract based on this notice or otherwise pay for information solicited. This is not a Request for Proposal (RFP). This is a pre-solicitation for planning purposes only, and shall not be construed as a solicitation or as an obligation on the part of the FDA. The FDA will not accept unsolicited proposals in response to the subject of this request for capabilities statements. Please ensure the Request for Capability Statement (RFC) number FDA-RIM-00014 and program title (FDA RIM 2014) is referenced on all correspondence. Telephone requests for this Presolicitation Notice will not be honored and no prospective Offerors list shall be maintained. FDA will utilize an advisory multistep process in order to provide guidance to industry for responding to the forthcoming request for proposal (RFP). The advisory multi-step process will consist of an evaluation of a potential offeror's overall capability related to the requirements specified in the pre-solicitation notice (Step 1), followed by posting of the solicitation, and receipt and evaluation of proposals (Step 2). This Advisory Multi-Step Process is described in FAR 15.202, which states: (a) The agency may publish a presolicitation notice (see 5.204) that provides a general description of the scope or purpose of the acquisition and invites potential offerors to submit information that allows the Government to advise the offerors about their potential to be viable competitors. The presolicitation notice should identify the information that must be submitted and the criteria that will be used in making the initial evaluation. Information sought may be limited to a statement of qualifications and other appropriate information (e.g., proposed technical concept, past performance, and limited pricing information). At a minimum, the notice shall contain sufficient information to permit a potential offeror to make an informed decision about whether to participate in the acquisition. This process should not be used for multi-step acquisitions where it would result in offerors being required to submit identical information in response to the notice and in response to the initial step of the acquisition. (b) The agency shall evaluate all responses in accordance with the criteria stated in the notice, and shall advise each respondent in writing either that it will be invited to participate in the resultant acquisition or, based on the information submitted, that it is unlikely to be a viable competitor. The agency will advise respondents considered not to be viable competitors of the general basis for that opinion. The agency shall inform all respondents that, notwithstanding the advice provided by the Government in response to their submissions, they may participate in the resultant acquisition. In accordance with the FAR guidance above, the FDA will review each Offeror's submitted pre-solicitation response, which will include a capability statement and responses to specific questions about their experience with the services required under this acquisition. The FDA determination of each Offeror as a viable/non-viable competitor will then be provided as an advisory response, based on the information submitted. Step 1 of the advisory multi-step process consists of the following: 1. Presolicitation Notice: The requirement, the selection process description, and technical capability questions are provided on FedBizOpps. This initial posting is provided to enable potential offerors to make an informed decision about whether to participate in the acquisition. 2. In order to respond to the Presolicitation, potential offerors may submit a pre-solicitation response, which must include a capability statement and responses to the technical questions provided with the Presolicitation Notice. 3. The FDA will then review all pre-solicitation responses, for determination of a viable/non-viable competitor recommendation. 4. The FDA will notify potential offerors of the determination of a "viable" or "non-viable" competitor: o For the purposes of this process, Offerors determined to be "viable competitors" will be advised to submit a proposal once the solicitation has been posted on FedBizOpps. Determination that an offeror is a viable competitor is provided for advisory purposes only; it does not constitute a determination of technical acceptability for the acquisition. o Potential offerors determined to be "non-viable competitors" will provided the general basis for the Government's determination. Determination that an offeror is a non-viable competitor is provided for advisory purposes only; it does not constitute a downselect or removal of the offeror from the competition. Step 2 of the advisory multi-step process consists of the following: • The FDA will post a solicitation (request for proposals) for onsite Record Information Management (RIM) support services on FedBizOps. Deadlines for submission of questions and for the submission of final proposals will be included. • The FDA will receive all proposals from offerors, regardless of the viable/non-viable determination whether they paticiapted in this advisory process. • The FDA will evaluate all offers received (regardless of the "viable" versus "non-viable" determination) against requirements of the solicitation, based on the stated evaluation factors. This includes both a technical and cost evaluation. • Based on the technical and cost evaluation detailed in the solicitation, the FDA will provide notification of award based on best value. CONTRACTOR CAPABILITY STATEMENT INSTRUCTIONS: The Government expects a capability statement only from qualified prime contractors. The FDA requests that potential sub-contractors or partners refrain from submitting capability statements. Refer to the Draft SOW for an overview of the Government initiative. Firms should respond to the Presolicitation Notice by addressing the topics listed below. 1. Page Count: Page size shall be 8.5 by 11 inches. Margins shall be set at one inch on top and bottom and both sides. Minimum type size shall be 12 point Arial standard font with single spacing. Submissions must be submitted in Microsoft Word 2000 (or newer version). Total page count of the capability statement shall not exceed fifteen (15) pages, not including cover page, table of contents, attachments, and/or charts. Any information submitted in excess to the page limitation WILL NOT be reviewed. 2. Business size for NAICS XXXX (size standard $ or number of employees) and status, if qualified as an 8(a) firm (must be certified by SBA), Small Disadvantaged Business (must be certified by SBA), Woman-Owned Small Business, HUBZone firm (must be certified by SBA), and/or Service-Disabled Veteran-Owned Small Business (must be listed in the VetBiz Vendor Information Pages). 3. DUNS number, CAGE Code, Tax Identification Number, and company structure (Corporation, LLC, partnership, joint venture, etc.). Companies also must be registered in the System for Award Management (SAM, at www.sam.gov) to be considered as potential sources. 4. Identification of the firm's GSA Schedule contract(s) by Schedule number and contract number and SINs that are applicable to this potential requirement are also requested. SUBMISSION FORMAT: The contractor shall submit the capability statement response and information in the order of the topic areas: 1) Corporate History/Overview, 2) Experience, and 3) Technical Capability. All responses shall be addressed in the order listed below. Corporate History/Overview/ and Capabilities: A. Provide a description of your company, primary service area, total number of employees, number of employees available to work this effort based on current workload, and viability of program requirements. Indicate the extent of subcontracting and / or joint ventures, if any, to include the number of subcontractors that would be necessary to support this effort. B. Describe how your company's organizational structure and available resources will assist in meeting the task areas identified in the IDIQ SOW. C. Describe your company's ability to accommodate to relocations and movement towards an electronic submissions environment. D. Describe your company's ability to manage multiple task orders and effectively communicate with FDA stakeholders. E. Describe your company's ability to conduct quality control, adhere to Acceptable Quality Levels (AQLs), and meet Service Level Agreements (SLAs). F. Describe your company's ability to recruit qualified personnel. 2. Experience: A. Describe your company's experience in managing a program of similar size, scope, and complexity of the FDA's Records Information Management (RIM) requirement. B. Describe your company's experience handling non-public information and the security measure that would be implemented to ensure safe-handling of FDA information. C. Describe your company's experience in performing task areas identified in IDIQ SOW. D. Describe your company's experience in accommodating to changes in regulations and policies related to records management. 3. Technical Capability: A. Identify your company's capabilities in the task areas identified in the IDIQ SOW. Please note; the contractor must demonstrate the ability to meet the requirements in all task areas. STEP 1 - DETERMINATION OF VIABILITY The determination of viability will focus upon the degree to which the contractor has provided records lifecycle services similar in size, scope, and complexity. The contractor's capability submission must indicate that it can provide and perform all the tasks areas identified in the IDIQ SOW. The Contractor Capability Statement will be evaluated based upon the areas identified below: 1) Corporate Overview /History/ and Capabilities: The contractor must demonstrate the ability to provide an adequate number of resources with the appropriate skill level to support FDA's RIM requirements. 2) Experience: Demonstrated experience in providing Records Management services. Specific areas of experience includes processing physical and electronic records material; collection maintenance activities, and best practice consulting and training services. 3) Technical Capability: Significant and demonstrated evidence that the contractor can provide and perform the task areas identified in the IDIQ SOW. * This requirement is a competitive 8(a) requirement. Eligibility will be verified, please submit your 8(a)/SBA Case # and DUNS with your capability statement. ** All eligible contractors must be able to perform these services in Washington, DC. *** All responses shall be submitted to Elvis R. Colbert, via email at Elvis.Colbert@fda.hhs.gov no later than 5:00pm (ET) on Friday August 23, 2013. Please note that no telephone calls will be accepted.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-On-Site-RIM-00014/listing.html)
- Place of Performance
- Address: FDA Centers (Various Locations), Various, Maryland, Various, United States
- Record
- SN03146890-W 20130815/130813235427-5fa5678a4905dad4127bbe03d4fe8451 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |